When the Target Is Not the Driver: Rethinking LDL in Cardiac Allograft Vasculopathy.

Association Between Ultraprocessed Food Consumption and Cardiovascular Disease Risk: MESA (Multiethnic Study of Atherosclerosis).

Targeting Triglycerides in Cardiovascular Disease Prevention: Evidence, Mechanisms, and Emerging Therapies.

Liver Fibrosis and the Risk of Coronary Artery Disease, Stent Thrombosis, Restenosis and Adverse Clinical Outcomes.

The Continuum of Prevention and Heart Failure in Cardiovascular Medicine: A Joint Scientific Statement from the Heart Failure Society of America and The American Society for Preventive Cardiology.

Evaluation of the PREVENT risk assessment tool and visceral adiposity: Insights from the UK Biobank.

Relationship between 10- and 30-year PREVENT Risk Scores with Coronary Artery Calcium and Incident Atherosclerotic Cardiovascular Disease: MESA.

Effect of glucagon-like peptide-1 receptor agonists on heart failure outcomes and cardiovascular death across varying cardiovascular-kidney-metabolic comorbidity.

Current Clinical Trials for Treating Elevated Lipoprotein(a).

2025 ACC/AHA/ASE/ASNC/SCCT/SCMR Advanced Training Statement on Advanced Cardiovascular Imaging: A Report of the ACC Competency Management Committee.